⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TXMD News
TherapeuticsMD, Inc.
Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson
globenewswire.com
ABBV
AZN
PFE
NVS
JNJ
AMGN
BMY
GILD
BIIB
TXMD
UTHR
Form 8-K
sec.gov
TXMD
TIXiMED Appoints Stephen Daly and Albert R. Collinson, Ph.D., to Board of Directors
businesswire.com
TXMD
Form 8-K
sec.gov
TXMD
TherapeuticsMD Announces First Quarter 2026 Financial Results
businesswire.com
TXMD
Form 8-K
sec.gov
TXMD
TherapeuticsMD Announces Full Year 2025 Financial Results
businesswire.com
TXMD
TIXiMED Announces Expansion of Program-Related Investment from the Helmsley Charitable Trust
businesswire.com
TXMD
TherapeuticsMD Announces Third Quarter 2025 Financial Results
businesswire.com
TXMD